Collection of Outcomes Data for Pregnant Patients With Cancer

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
No phase specifiedHealth services research, Natural history/EpidemiologyActiveNo age specifiedOther2005-0518

Trial Description


The goal of this research study is to collect information on patients who are or were pregnant while diagnosed with cancer and to store this information in a research database.

Further Study Information

If you agree to take part in this study, information about the type of cancer, the type of treatment you have had or are having, and details about your pregnancy will be collected for the database. Data will be collected from patients seen at MD Anderson since September 2003 until data has been collected for 500 cases. This information will serve as a basis for future studies about pregnant women with cancer. You will receive no special tests or treatment at MD Anderson as a result of this study.

Progress notes and ultrasound reports about your pregnancy will be requested from Maternal Fetal Medicine and/or from your personal obstetrician. This information will be entered into the database and also included in your medical record. If the information is not consistent in the record, we may contact you to clarify the information. You will remain on study until your pregnancy and/or any treatment you are receiving are completed.

Periodically the database will be updated to include information about patient survival. This information is usually found in the medical record however it may be necessary to contact you directly.

This is an investigational study. About 500 patients will take part in this study. All will be enrolled at MD Anderson.

Eligibility Criteria

Inclusion Criteria:

1. All pregnant patients with cancer and patients known to have been pregnant with a diagnosis of cancer are eligible, regardless of their diagnosis or treatment plan.

2. Patients may receive prenatal care from any obstetrician, but a consult with a Maternal Fetal Medicine physician is encouraged.

Exclusion Criteria:


Trial Contact Information

Trial Lead Organizations/Sponsors

M. D. Anderson Cancer Center at University of Texas

    Andrea Milbourne, MD, Principal Investigator
    Sue Rimes, RN
    Ph: 713-563-4546

    Trial Sites



    M. D. Anderson Cancer Center at University of Texas

    Andrea Milbourne, MD
    Principal Investigator

    Link to the current record.
    NLM Identifier NCT00507572 processed this data on April 16, 2015

    Note: Information about this trial is from the database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the record to standardize the names of study sponsors, sites, and contacts. only lists sites that are recruiting patients for active trials, whereas lists all sites for all trials. Questions and comments regarding the presented information should be directed to